Close

Warning

You are about to leave ethypharm.com

Regulations vary by country. The information provided on the website you wish to visit may not correspond to that of your country.

Click on CONTINUE if you wish to access the site of one of our subsidiaries.

Continue
Acquisition of Argatroban business in Europe

Ethypharm has entered into an agreement with Mitsubishi Tanabe Pharma Corporation (MTPC) to acquire the selective antithrombin agent, Argatroban monohydrate (Argatra®, Arganova®, Novastan®, Exembol®), in Europe.